Latest posts
-
Cell-Free Regenerative Medicine: How Engineered Exosomes Are Replacing Stem Cell Therapy in Next-Generation Clinical Protocols
For two decades, stem cell therapy dominated regenerative medicine. But clinical reality has revealed challenges: immune rejection, tumorigenic risk, inconsistent engraftment, and manufacturing complexity. The field is pivoting from cell-based to cell-free regeneration, with engineered exosomes leading this transformation. Stem Cell Limitations While hematopoietic stem cell transplantation saves thousands annually, most regenerative applications face persistent…
-
Exosome Biomarker Discovery from Liquid Biopsy: Extracellular Vesicle Cargo Signatures as Next-Generation Diagnostic Tools
The diagnostic paradigm is shifting from tissue to liquid biopsy. Exosome-based liquid biopsy has emerged as the most information-rich approach. Unlike ctDNA or CTCs, exosomes carry a comprehensive molecular snapshot: proteins, lipids, DNA, all RNA species, and metabolites. This positions exosome cargo signatures as next-generation diagnostic biomarkers. Why Exosomes Excel as Diagnostic Carriers Exosomes are…